Replies to post #91422 on Biotech Values

[ghmm]

I thought the difference in VX-222 dose was rather interesting. I was surprised the FDA would permit them to test VX-222 for as long as they are without more monotherapy (+ SOC) data. But obviously I am biased ;-)

[genisi]

What percentage of undetectable treatment-naive patiens were in the INFORM-1 after 14 days, 25% or so with the higher doses?